Back to Search
VANSI GANDHI, PHARMD
PHARMD
Pharmacist
NPI: 1164246203Individual
Specialties, Licenses & Credentials
Research & Publications (20)
A unique RNA-directed nucleoside analog is cytotoxic to breast cancer cells and depletes cyclin E levels.
PMID 19641990·Breast Cancer Res Treat·2010
8-other
B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.
PMID 19491390·Blood·2009
7-preclinical
Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial.
PMID 19242495·Leukemia·2009
2-rct
Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia.
PMID 19234140·Blood·2009
8-other
Myeloma antioxidant status: the good, the bad and the reactive.
PMID 19347768·Leuk Lymphoma·2009
6-review
Targeting MET transcription as a therapeutic strategy in multiple myeloma.
PMID 18509644·Cancer Chemother Pharmacol·2009
8-other
PROMISE: a tool to identify genomic features with a specific biologically interesting pattern of associations with multiple endpoint variables.
PMID 19528086·Bioinformatics·2009
8-other
Transcription inhibition of heat shock proteins: a strategy for combination of 17-allylamino-17-demethoxygeldanamycin and actinomycin d.
PMID 19383903·Cancer Res·2009
8-other
Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer.
PMID 19143569·J Med Chem·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 400 W 23RD ST
LAWRENCE, KS 66046 - Phone
- (785) 832-8388
Quick Facts
- NPI
- 1164246203
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile